5Moore PE,Church TL,Chism DD, et al. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells:a role for ERK[J] .Am J Physiol Lung Cell Mol Physiol,2002,282(4) :L847-L853.
6Kampen GT, Stafford S, Adachi T, et al. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases[ J]. Blood, 2000,95 (6) : 1911-1917.
7Boehme SA, Sullivan SK, Crowe PD, et al. Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration[J].J Immuol, 1999,163(3) : 1611-1618.
8Bates ME,Green VL, Bertics PJ. ERK1 and ERK2 activation by chemotactic factors in human eosinophils is interleukin 5-dependent and contributes to leukotriene C(4) biosynthesis [J]. J Biol Chem,2000,275(15) : 10968-10975.
9Furuichi S, Hashimoto S, Gon Y, et al. p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase regulate interleuldn-8 and RANTES production in hyperosmolarity stimulated human bronchial epithelial cells [J]. Respirology,2002,7(3) : 193-200.
10Werle M,Schmal U,Hanna K, et al. MCP-1 induces activation of MAP-kinase ERK,JNK and p38MAPK in human endothelial cells[J].Cardiovasc Res,2002,56(2) :284-292.
二级参考文献50
1Alam R, York J, Boyars M, et al. Increased MCP -1, RANTES, and MIp- 1 alpha in bronchoalveolar lavage fluid of allergic asthmaticpatien[J]. Am J Respir Crit Care Med, 1996,153(4 Pt 1):1398 - 1404.
2During J, de Wynte EA, Kasper C, et al. Expression of mactophage inflammatory protein-1a receptors in human CD34+ hematopoietic cells and their modulation by tumor necrosis factor- a and interferon - γ[J]. Blood, 1998,92(9):3073 - 3081.
3Broxmeyer HE, Cooper S, Hangoc G, et al. Dominant myelopoietic effector functions mediated by chemokine receptor CCRl[J]. J ExpMed, 1999,189(12):1987 - 1992.
4Taub DD, Conlon K, Lloyd AR, et al. Pre ferential migration ofactivated CD4+ and CD8+ T cells in response to MIP - 1 α and MIP - 1 β[J]. Science, 1993,260(5106):355 - 358.
5Tillie- Leeblond I, Hanmand H, Desurmont S, et al. CC chemokines and interleulkin- 5 in bronchial lavage fluid from patients with status asthmathicus. Potential implication in eosinophil recruitment[J]. Am J Respir Ctit Care Med, 2000,162(2 Pt 1):586-592.
6Lee SC, Brummet ME, Shahabuddin S, et al. Cutaneous injection of human subjects with macrophage inflan-natory protein- 1 alphainduces significant recmitment of neutriphils and monocytes[J]. J Immunol, 2000,164(6):3392 - 3401.
7Koch AE, Kunkei SL, Harlow LA, et al. Macrophage inflammatory protein-1 a novel chemotactic cytokine for macrophages in rheumatoid arthritis[J]. J Clin Invest, 1994,93(3):921 -928.
9Holgate ST, Bodey KS, Janezic AJ, et al. Release of RANTES,MIP - 1α, and MCP - 1 into asthmatic airways following endobronchial allergen challenge[J]. Am J Respir Care Meal, 1997,156 (5):1377 - 1383.
10Cruikshank WW, Long A, Tarpy RE, et al. Early identification of intedeukin- 16(lymphocyte chemoattmctant factor) and macrophage inflammatory protein 1 alpha (MIP 1 alpha) in bronchoalveolar lavage fluid of antigen -challenged asthmatics[J]. Am J Respir Cell Mol Biol, 1995,13(6):738 - 747.
4Baggiolini M. Chemokines and leukocyte traffic[J]. Nature, 1998,392(6678): 565- 568.
5Message SD, Johnston SL. Host defense function of the airway epithelium in health and disease: clinical background[ J ]. J Leukoc Biol, 2004,75 ( 1 ) : 5 - 17.
